The Real-World Effectiveness Of Natalizumab And Fingolimod In Relapsing-Remitting Multiple Sclerosis. An Italian Multicentre Study.
ConclusionsBoth drugs were highly effective in our cohort. Natalizumab proved superior in inducing regression of disability and 2-year-NEDA-3.
Source: Multiple Sclerosis and Related Disorders - Category: Neurology Source Type: research
More News: Brain | Disability | Gilenya | Italy Health | Multiple Sclerosis | Neurology | Study | Tysabri